No Data
Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025
TD Cowen Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $72
Investing in Vericel (NASDAQ:VCEL) Five Years Ago Would Have Delivered You a 216% Gain
Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $67
TD Cowen Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $72
Vericel (VCEL) Receives a Buy From TD Cowen